Skip to content
10-K

Annual Report

PRESSURE BIOSCIENCES, INC.

0001493152-23-012010

← back to feed
Filed
Apr 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 31, 2023 15.87M sh
Capex FY 2022 · Dec 31, 2021 $122.95K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$4.87M
Cash And Equivalents FY 2022 · Dec 31, 2021 $132.31K
Current Liabilities FY 2022 · Dec 31, 2021 $24.63M
Total Liabilities FY 2022 · Dec 31, 2021 $25.04M
Current Assets FY 2022 · Dec 31, 2021 $1.86M
Total Assets FY 2022 · Dec 31, 2021 $2.83M
Eps Basic FY 2022 · Dec 31, 2021 −$3.42
Sga Expense FY 2022 · Dec 31, 2021 $3.82M
Rd Expense FY 2022 · Dec 31, 2021 $1.1M
Net Income FY 2022 · Dec 31, 2021 −$20.15M
Operating Income FY 2022 · Dec 31, 2021 −$4.19M
Cost Of Revenue FY 2022 · Dec 31, 2021 $942.38K
Revenue FY 2022 · Dec 31, 2021 $2M
Stockholders Equity FY 2022 · Dec 31, 2020 −$16.92M
Stockholders Equity FY 2022 · Aug 30, 2020 $473.03K